Global Neurology Academy

The Global Neurology Academy (GNA) series offers certified education modules and video interviews from leading MS experts from across the globe as they address topics such as induction therapy in relapsing-remitting multiple sclerosis; No Evidence of Disease Activity (NEDA) concept; how different agents used in MS management may be utilized in induction therapy; appreciation of how reductions in end-organ damage impact patient quality-of-life; mechanisms of action of the classical as well as emergent agents; key issues associated with making the correct differential diagnosis of multiple sclerosis, in addition to how best to incorporate prognostic indicators into clinical decision-making; current and emergent novel oral agents in MS management; and diagnostic strategies and identifying predictors of outcome.

For more information about GNA, visit www.globalneurologyacademy.org.

403

LikeLikedUnlike

Episodes 61-75 of 183

Transforming Clinician Wellness: EEG Headphones Helping with Burnout
NeuroFrontiers
Transforming Clinician Wellness: EEG Headphones Helping with Burnout
- John Golden
  Peer
- Michael Greenberg, MD
  Peer
Prioritizing Patient-Centered, Multidisciplinary Care in CIDP
On the Frontlines of CIDP
Prioritizing Patient-Centered, Multidisciplinary Care in CIDP
- Andrew G. Lee, MD
  Peer
- Ashley Baker, MSN, PMHNP
  Peer
Identifying CIDP: A Guide to Risk Profiles and Clinical Presentation
On the Frontlines of CIDP
Identifying CIDP: A Guide to Risk Profiles and Clinical Presentation
- Nicolas Dubuisson, MD
  Peer
- Ryan Quigley
  Peer
Spinal Muscular Atrophy Care: Optimizing Therapeutic Decision Making
NeuroFrontiers
Spinal Muscular Atrophy Care: Optimizing Therapeutic Decision Making
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- John Brandsema, MD
  Peer
Gene Therapy Safety in DMD: How to Identify Common Immune Reactions
NeuroFrontiers
Gene Therapy Safety in DMD: How to Identify Common Immune Reactions
- Kaitlin Batley, MD
  Peer
Optimizing DMD Care Through Multidisciplinary Collaboration
NeuroFrontiers
Optimizing DMD Care Through Multidisciplinary Collaboration
- Kaitlin Batley, MD
  Peer
advertisement
Symptom Control in gMG: Comparing Ravulizumab and Efgartigimod
NeuroFrontiers
Symptom Control in gMG: Comparing Ravulizumab and Efgartigimod
- Christopher A. Scheiner, MD, PhD
  Peer
Exploring Timing in MS Therapy: Real-World Outcomes of Fumarates
NeuroFrontiers
Exploring Timing in MS Therapy: Real-World Outcomes of Fumarates
Managing MS in Older Adults: Top 5 Clinical Considerations
NeuroFrontiers
Managing MS in Older Adults: Top 5 Clinical Considerations
- Yinan Zhang, MD
  Peer
Empowering Patients with CIDP: Education, Support, and Personalized Care Strategies
On the Frontlines of CIDP
Empowering Patients with CIDP: Education, Support, and Personalized Care Strategies
- Danielle Minetti
  Peer
- Ryan Quigley
  Peer
New Frontiers in CIDP Care: Exploring Approved and Emerging Therapies
On the Frontlines of CIDP
New Frontiers in CIDP Care: Exploring Approved and Emerging Therapies
- Chafic Karam, MD
  Peer
- Ryan Quigley
  Peer
Updates from MINT: Inebilizumab Reduces Relapses and Rescue Therapy Use
NeuroFrontiers
Updates from MINT: Inebilizumab Reduces Relapses and Rescue Therapy Use
- Richard Nowak, MD, MS
  Peer
advertisement
Innovations in Bladder Monitoring for MS: Advancing Remote Evaluation Tools
NeuroFrontiers
Innovations in Bladder Monitoring for MS: Advancing Remote Evaluation Tools
- Riley Bove, MD, MMSc
  Peer
How Diagnostic Delays in gMG Impact Disease Severity, Outcomes, and Quality of Life
NeuroFrontiers
How Diagnostic Delays in gMG Impact Disease Severity, Outcomes, and Quality of Life
- John A. Morren, MD, FAAN, FAANEM
  Peer
Managing MS in Women: How to Guide Patients Through Pregnancy and Menopause
NeuroFrontiers
Managing MS in Women: How to Guide Patients Through Pregnancy and Menopause
- Riley Bove, MD, MMSc
  Peer